RDW-platelet ratio (RPR), PLR-NLR and WBC--MPV ratios. It was shown that some hematologic parameters such as MPV, RDW, NLR and PLR may play a role in predicting worse outcomes in patients with STEMI undergoing pPCI [4] [5] [6] . Our group previously found that admission PDW and MPV are independent correlates of 'no-reflow' and in-hospital major adverse cardiac events (MACEs) among patients with STEMI undergoing pPCI [7] . Moreover, we also showed that female gender, pain to balloon time, high Thrombolysis in Myocardial Infarction (TIMI) thrombus grade, tirofiban, MPV, and PLR were independent predictors of 'no--reflow' in young patients with STEMI after pPCI [8] . What is more, we tried to evaluate the relations between pre-procedural RPR and the in-hospital and long-term outcomes in 580 STEMI patients undergoing pPCI [9] . In that study, pain to balloon time, multivessel disease, TIMI thrombus grade, tirofiban, aspirin, previous coronary artery disease, NLR, platecrit, and RPR remained independent predictors of 'no-reflow' after pPCI on multivariate analysis. Patients in 'no-reflow' group tended to constitute a higher percentage of in-hospital MACE, including nonfatal myocardial infarction and cardiovascular mortality compared to the reflow patients. We concluded that admission NLR, platecrit, and RPR are independent correlates of 'no-reflow' and in-hospital MACEs among patients with STEMI undergoing pPCI.
In summary, admission complete blood cell parameters are easily obtained bedside for the prediction of short-and long-term mortality in patients with STEMI undergoing pPCI. From that point of view we strongly believe that further large-scale prospective trials are urgently needed to clarify the exact role of complete blood cell parameters in predicting short-and long-term mortalities in that patient setting.
